$VISK

Viskase Holdings 3Q 2026: Revenue $95.28M, Net income ($6.4M), EPS ($0.45) — 10-Q Summary

Viskase Holdings reported 3Q 2026 revenue of $95.28M, up 4.5% YoY, with a net loss of $6.4M, improved from $12.98M YoY. EPS loss was $0.45, better than $2.4 a year earlier. Sales growth was driven by higher volume, pricing, and product mix, while nine-month sales declined 3.8% due to lower volume and capacity constraints.

Original reporting
Published Nov 3, 2026, 11:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Viskase Holdings 3Q 2026: Revenue $95.28M, Net income ($6.4M), EPS ($0.45) — 10-Q Summary — source image
Decision brief

The 30-second read

$VISKNeutralLow
01

Why it matters

The earnings release shows incremental improvement but remains a loss, suggesting limited immediate trading opportunities.

02

Market read

Micro-cap earnings release with modest improvement; low immediate trading relevance.

03

What to watch

Potential cost pressures from raw material price volatility and the recent Arkansas plant closure.

Relevance 6/10Novelty 6/10Timing: post-market today

Background

Viskase Holdings is a specialty packaging company that recently completed restructuring of its Arkansas plant.

Company-level read

Ticker impact

$VISKNeutralMedium confidence
Context

Viskase Holdings reported Q3 2026 revenue of $95.28M and a narrowed net loss of $6.4M, the first disclosure of these figures.

Expected impact

potential modest upside as the market prices in improved loss profile

Evidence & confidence

Small-cap earnings with limited scale; improvement is modest and may not trigger a large move.

Market effects

Provides a minor data point for the packaging and foodservice materials sector, indicating slight recovery trends.

Limited to U.S. small-cap investors; no broader regional effect.

Minimal global impact due to company size and niche market.

Counterpoint

The loss narrowing may be temporary; underlying capacity constraints could limit future upside.

Key entities

  • Viskase Holdings, Inc.

    Specialty packaging manufacturer reporting Q3 2026 results.

Related articles

$CRTOMed

Criteo (CRTO) Q3 2026 Earnings Call Transcript

Criteo (CRTO) reported stable spending trends among large performance media clients in Q3 2026, with growth in CTV and AI platforms. The company is expanding its CTV offering globally and integrating with AI platforms like ChatGPT Ads, showing early commercial traction. Criteo aims to strengthen financial performance by deepening client relationships and improving self-service capabilities.

$BCRXMedAI 8/10

BioCryst (BCRX) Q3 2026 Earnings Call Transcript

BioCryst (BCRX) reported Q3 2026 earnings, highlighting growth in ORLADEYO pellet usage among children and a transition to CareMed as their sole pharmacy partner. The company expects to announce top-line data for navenibart in Q3 2027 and is on track to share early clinical data for BCX1771 by year-end. Revenue was $174.8 million, with ORLADEYO revenue increasing 20% year-over-year. The company anticipates continued revenue growth and cost savings in 2027.

$OCGNMed

Ocugen (OCGN) Q3 2026 Earnings Call Transcript

Ocugen reported Q3 2026 progress, with all three late-stage gene therapy programs in phase III. OCU400 for retinitis pigmentosa completed enrollment, with top-line data expected in Q1 2027. The company secured a $4M upfront license deal for the Middle East and North Africa. Financials showed $84.6M in cash and a $0.01 net loss per share, down from $0.07 in 2025. Ocugen aims to file three BLAs by 2028.

$ADVMed

Advantage (ADV) Q3 2026 Earnings Call Transcript

Advantage (ADV) reported Q3 2026 revenue up 3% and Adjusted EBITDA down 3%, with Experiential Services growing 11% and Retailer Services returning to growth. Branded Services underperformed, but the company expects improvement. They announced a restructuring plan aiming for $25M in annual savings. The company forecasts double-digit revenue and Adjusted EBITDA growth for Q4 and the full year, with margin expansion.